New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Genetic testing for prostate cancer increases after introduction of point-of-care program

Genetic testing for prostate cancer increases after introduction of point-of-care program

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainSome patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing progr
Oncology January 02,2024
Genetic testing for prostate cancer increases after introduction of point-of-care program

Genetic testing for prostate cancer increases after introduction of point-of-care program

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainSome patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing progr
Oncology January 02,2024
Molecular mechanisms regulating prostate cancer hypoxia identified

Molecular mechanisms regulating prostate cancer hypoxia identified

by Melissa Rohman,Northwestern UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A Northwestern Medicine
Oncology January 02,2024
Molecular mechanisms regulating prostate cancer hypoxia identified

Molecular mechanisms regulating prostate cancer hypoxia identified

by Melissa Rohman,Northwestern UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A Northwestern Medicine
Oncology January 02,2024
Prostate cancer test: Is it time to ditch the digital rectal examination?

Prostate cancer test: Is it time to ditch the digital rectal examination?

by Stephen Hughes,The ConversationA man having his prostate gland examined. Credit: National Cancer Institute/WikimediaThe finger-up-the-bottom examination for prostate cancer has been drawn int
Oncology January 02,2024
Prostate cancer test: Is it time to ditch the digital rectal examination?

Prostate cancer test: Is it time to ditch the digital rectal examination?

by Stephen Hughes,The ConversationA man having his prostate gland examined. Credit: National Cancer Institute/WikimediaThe finger-up-the-bottom examination for prostate cancer has been drawn int
Oncology January 02,2024
New treatment approach for prostate cancer could stop resistance in its tracks

New treatment approach for prostate cancer could stop resistance in its tracks

bySanford Burnham Prebys Medical Discovery InstituteProstate cancer cells. Credit: NIH Image GalleryFor the first time, researchers have discovered that prostate cancer can be killed by targetin
Oncology January 02,2024
New treatment approach for prostate cancer could stop resistance in its tracks

New treatment approach for prostate cancer could stop resistance in its tracks

bySanford Burnham Prebys Medical Discovery InstituteProstate cancer cells. Credit: NIH Image GalleryFor the first time, researchers have discovered that prostate cancer can be killed by targetin
Oncology January 02,2024
Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred
Oncology January 02,2024
Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

Prostate cancer: Getting ever closer to diagnosis using an 'electronic nose'

by Politecnico di MilanoPrototype of an electronic nose developed by the Politecnico di Milano in partnership with Humanitas, capable of diagnosing a tumor using a urine sample with 82% accuracy. Cred
Oncology January 02,2024
Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther
Oncology January 02,2024
Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther
Oncology January 02,2024
Cesarean section tied to higher risk for later leukemia in offspring

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog
Oncology January 02,2024
Cesarean section tied to higher risk for later leukemia in offspring

Cesarean section tied to higher risk for later leukemia in offspring

Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 inHematological Oncolog
Oncology January 02,2024
Estimating the environmental impact of prostate cancer procedures

Estimating the environmental impact of prostate cancer procedures

by Cheri Lewis,Yale UniversityCredit: Unsplash/CC0 Public DomainA Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way t
Oncology January 02,2024
Estimating the environmental impact of prostate cancer procedures

Estimating the environmental impact of prostate cancer procedures

by Cheri Lewis,Yale UniversityCredit: Unsplash/CC0 Public DomainA Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way t
Oncology January 02,2024
Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

by Association for Molecular PathologyAMP/ASCO/CAP Somatic Variants Guideline Implementation Survey—Selected Results. Panel A: Q1: Have you implemented the AMP/ASCO/CAP somatic variant classification
Oncology January 02,2024
Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

Assessing clinical implementation of past standards for interpretation and reporting of sequence variants in cancer

by Association for Molecular PathologyAMP/ASCO/CAP Somatic Variants Guideline Implementation Survey—Selected Results. Panel A: Q1: Have you implemented the AMP/ASCO/CAP somatic variant classification
Oncology January 02,2024
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res
Oncology January 02,2024
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res
Oncology January 02,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com